Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.
Niamh Panesar
Advertisement
Niamh Panesar is CMC senior manager at Kinapse Ltd, UK.
Articles by Niamh Panesar
Advertisement
Latest Updated Articles
Nitrosamine Impurities in Medicinal ProductsDecember 2nd 2020
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
5